The knockdown of TOX ameliorated the exhaustion state of CD8+ T cells, enhancing the response to ICB treatment in an HCC mouse model (234), suggesting a new strategy to maximize immunotherapeutic efficacy by the downregulation of TOX expression. This evidence concerns the gene TOX and hepatocellular carcinoma.